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Background: The use of drug-eluting stent (DES) is associated with excellent clinical and angiographic results in bifurcation lesions. However, 
there is limited angiographic and clinical follow-up data after single DES implantation with final kissing inflation (FKI) for bifurcation lesions in 
diabetic patients.
Methods: From the prospective randomized study of SINGLE KISS trial to assess the efficacy of single stent strategy with FKI after stent 
implantation using by sirolimus- (SES) and paclitaxel-eluting stents (PES) for 824 bifurcation lesions, 341 lesions in 341 diabetic patients were 
selected to evaluate one year clinical results and 9 month quantitative angiographic analysis.
Results: Up to date, 724 patients completed one year follow-up. One-year clinical and 9 months angiographic results were similar between the 
two stent groups (Table). However, binary restenosis, target lesion revascularization, and target vessel revascularization rates of diabetic group were 
significantly higher than non diabetic group after SES implantation. 
Conclusions: Single stent strategy with FKI using by SES and PES were similar and effective for bifurcation lesions in diabetic patients. 
Angiographic and clinical results (* = p <0.05 comapred with non diabetic group)
DM Non DM
SES (n = 162) PES (n =179) p SES (n = 247) PES (n =236) p
Binary restenosis rate in main branch 21 (13.0%)* 20 (11.2%) 0.62 11 (4.6%) 26 (11.2%) 0.01
Late loss in main branch 0.41±0.56mm 0.49±0.59mm* 0.32 0.34±0.77mm 0.65±0.77mm 0.0006
Binary restenosis rate in side branch 41 (25.3%)* 30 (16.8%) 0.07 27 (10.9%) 38 (16.0%) 0.23
Late loss in side branch 0.27±0.55mm 0.20±0.49mm 0.72 0.16±0.47mm 0.16±0.50mm 0.93
Death 0 10(0.6%) - 0 2 (0.8%) -
Myocardial Infarction 1 (0.6%) 1 (0.6%) - 2 (0.8%) 1 (0.4%) -
TLR 15 (9.3%)* 15 (8.1%) 0.56 8 (3.4%) 21 (8.9%) 0.02
TVR 19 (11.8%)* 17 (9.7%) 0.59 14 (5.7%) 26 (11.2%) 0.05
